Published in Arch Gen Psychiatry on September 01, 1999
Fluoxetine versus placebo in preventing relapse of major depression in children and adolescents. Am J Psychiatry (2008) 3.40
Reducing relapse and recurrence in unipolar depression: a comparative meta-analysis of cognitive-behavioral therapy's effects. J Consult Clin Psychol (2007) 2.22
Preventing recurrent depression using cognitive therapy with and without a continuation phase: a randomized clinical trial. Arch Gen Psychiatry (2001) 1.93
Antidepressant monotherapy vs sequential pharmacotherapy and mindfulness-based cognitive therapy, or placebo, for relapse prophylaxis in recurrent depression. Arch Gen Psychiatry (2010) 1.92
Cognitive-behavioral therapy to prevent relapse in pediatric responders to pharmacotherapy for major depressive disorder. J Am Acad Child Adolesc Psychiatry (2008) 1.79
Preventing depressive relapse and recurrence in higher-risk cognitive therapy responders: a randomized trial of continuation phase cognitive therapy, fluoxetine, or matched pill placebo. JAMA Psychiatry (2013) 1.77
A review of empirically supported psychological therapies for mood disorders in adults. Depress Anxiety (2010) 1.50
Imaging the serotonin transporter during major depressive disorder and antidepressant treatment. J Psychiatry Neurosci (2007) 1.46
Cognitive behavioral analysis system of psychotherapy and brief supportive psychotherapy for augmentation of antidepressant nonresponse in chronic depression: the REVAMP Trial. Arch Gen Psychiatry (2009) 1.35
Cognitive behavioral therapy for mood disorders: efficacy, moderators and mediators. Psychiatr Clin North Am (2010) 1.29
Modeling the complexity of post-treatment drinking: it's a rocky road to relapse. Clin Psychol Rev (2007) 1.20
Twelve-year depressive symptom trajectories and their predictors in a community sample of older adults. Int Psychogeriatr (2008) 1.15
Residual symptoms in depressed outpatients who respond by 50% but do not remit to antidepressant medication. J Clin Psychopharmacol (2011) 1.14
Partial remission, residual symptoms, and relapse in depression. Dialogues Clin Neurosci (2008) 1.04
Prevalence and outcome of partial remission in depression. J Psychiatry Neurosci (2002) 1.01
General practitioners' conceptions about treatment of depression and factors that may influence their practice in this area. A postal survey. BMC Fam Pract (2005) 0.98
Behavioral therapies for co-occurring substance use and mood disorders. Biol Psychiatry (2004) 0.97
Depressive rumination: investigating mechanisms to improve cognitive behavioural treatments. Cogn Behav Ther (2009) 0.95
Treatment strategies to improve and sustain remission in major depressive disorder. Dialogues Clin Neurosci (2008) 0.94
Moderators of continuation phase cognitive therapy's effects on relapse, recurrence, remission, and recovery from depression. Behav Res Ther (2010) 0.94
Which depressive symptoms remain after response to cognitive therapy of depression and predict relapse and recurrence? J Affect Disord (2009) 0.90
Efficacy of combined, sequential and crossover psychotherapy and pharmacotherapy in improving outcomes in depression. J Psychiatry Neurosci (2002) 0.90
Randomised controlled trial of the clinical and cost effectiveness of a specialist team for managing refractory unipolar depressive disorder. BMC Psychiatry (2010) 0.88
Do concomitant pain symptoms in patients with major depression affect quality of life even when taking into account baseline depression severity? Patient Prefer Adherence (2013) 0.86
The effects of cognitive therapy versus 'treatment as usual' in patients with major depressive disorder. PLoS One (2011) 0.86
Examination of the utility of psychotherapy for patients with treatment resistant depression: a systematic review. J Gen Intern Med (2010) 0.85
Stable remission and recovery after acute-phase cognitive therapy for recurrent major depressive disorder. J Consult Clin Psychol (2014) 0.85
Influence of psychotherapy attendance on buprenorphine treatment outcome. J Subst Abuse Treat (2005) 0.84
The Inventory Of Depressive Symptomatology (IDS-C(28)) is more sensitive to changes in depressive symptomatology than the Hamilton Depression Rating Scale (HAMD(17)) in patients with mild major, minor or subsyndromal depression. Eur Arch Psychiatry Clin Neurosci (2010) 0.82
A Randomized Controlled Trial of Mindfulness-Based Cognitive Therapy for Treatment-Resistant Depression. Psychother Psychosom (2016) 0.81
Quantifying and qualifying the preventive effects of acute-phase cognitive therapy: Pathways to personalizing care. J Consult Clin Psychol (2015) 0.81
The evolution of cognitive-behavioral therapy for psychosis. Psychol Res Behav Manag (2015) 0.80
Developing Cognitive Behavioral Therapy to Prevent Depressive Relapse in Youth. Cogn Behav Pract (2008) 0.78
Antidepressants and psychotherapy: a clinical research review. Dialogues Clin Neurosci (2005) 0.78
Prevention of recurrence of major depression among emerging adults by a group cognitive-behavioral/interpersonal intervention. J Affect Disord (2012) 0.77
Combination/augmentation strategies for improving the treatment of depression. Neuropsychiatr Dis Treat (2005) 0.77
[Psychotherapy in chronic depression]. Nervenarzt (2007) 0.77
Psychosocial determinants of recovery in depression. Dialogues Clin Neurosci (2008) 0.77
All you need is cognitive behaviour therapy? Critical appraisal of evidence base must be understood and respected. BMJ (2002) 0.76
Discontinuation of antidepressants during attempts to conceive: a pilot trial of cognitive behavioral therapy for the prevention of recurrent depression. J Clin Psychopharmacol (2014) 0.76
Patients with depression can be taught how to improve recovery. BMJ (2001) 0.76
Rumination-focused cognitive behaviour therapy vs. cognitive behaviour therapy for depression: study protocol for a randomised controlled superiority trial. Trials (2015) 0.75
Cognitive Behavioral Therapy for Depressed Adults with Mild Intellectual Disability: A Pilot Study. J Ment Health Res Intellect Disabil (2015) 0.75
The sequential approach to relapse prevention in unipolar depression. World Psychiatry (2002) 0.75
The need to teach cognitive-behavioural therapy. Sultan Qaboos Univ Med J (2009) 0.75
Psychoeducational and Cognitive Behavioral Treatment Programs: Implementation and Evaluation From 1995 to 2015 in Kraepelin's Former Hospital. Schizophr Bull (2016) 0.75
The sequence of the human genome. Science (2001) 101.55
Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet (1990) 25.12
High-resolution global maps of 21st-century forest cover change. Science (2013) 17.90
Graphic representation of pain. Pain (1976) 14.25
Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial. Lancet (2011) 10.73
Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group. Lancet (1993) 9.34
Increased absenteeism from work after detection and labeling of hypertensive patients. N Engl J Med (1978) 9.29
Inactivation of the beta-catenin gene by Wnt1-Cre-mediated deletion results in dramatic brain malformation and failure of craniofacial development. Development (2001) 9.00
A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine. Cell (1987) 7.25
Randomised clinical trial of strategies for improving medication compliance in primary hypertension. Lancet (1975) 7.22
Digital tomosynthesis in breast imaging. Radiology (1997) 5.82
Learned helplessness in humans: critique and reformulation. J Abnorm Psychol (1978) 5.40
Improvement of medication compliance in uncontrolled hypertension. Lancet (1976) 4.84
Exploring the effects of age of alcohol use initiation and psychosocial risk factors on subsequent alcohol misuse. J Stud Alcohol (1997) 4.59
Epidemiology of sepsis syndrome in 8 academic medical centers. JAMA (1997) 4.49
Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nat Genet (1999) 4.48
Complete nucleotide sequence of a milk-transmitted mouse mammary tumor virus: two frameshift suppression events are required for translation of gag and pol. J Virol (1987) 4.37
Preventing adolescent health-risk behaviors by strengthening protection during childhood. Arch Pediatr Adolesc Med (1999) 4.36
Relationship between occupations and asbestos-fibre content of the lungs in patients with pleural mesothelioma, lung cancer, and other diseases. Thorax (1977) 4.35
Anomalous origin of the left coronary artery from the pulmonary trunk. Its clinical spectrum, pathology, and pathophysiology, based on a review of 140 cases with seven further cases. Circulation (1968) 4.34
Mortality from epilepsy: results from a prospective population-based study. Lancet (1994) 4.31
Control of DNA synthesis genes in fission yeast by the cell-cycle gene cdc10+. Nature (1992) 4.13
A randomized trial of group outpatient visits for chronically ill older HMO members: the Cooperative Health Care Clinic. J Am Geriatr Soc (1997) 4.09
Sequence, topography and protein coding potential of mouse int-2: a putative oncogene activated by mouse mammary tumour virus. EMBO J (1986) 4.08
Choline containing metabolites during cell transfection: an insight into magnetic resonance spectroscopy detectable changes. FEBS Lett (2001) 3.88
Nest predation increases with parental activity: separating nest site and parental activity effects. Proc Biol Sci (2000) 3.73
Expression of Cre recombinase in mouse oocytes: a means to study maternal effect genes. Genesis (2000) 3.71
Pathway correcting DNA replication errors in Saccharomyces cerevisiae. EMBO J (1993) 3.57
Randomized trial of folic acid supplementation and serum homocysteine levels. Arch Intern Med (2001) 3.55
Coordination of expression of DNA synthesis genes in budding yeast by a cell-cycle regulated trans factor. Nature (1991) 3.53
Coordinated regulation of gene expression by the cell cycle transcription factor Swi4 and the protein kinase C MAP kinase pathway for yeast cell integrity. EMBO J (1996) 3.45
A multicopy suppressor gene of the Saccharomyces cerevisiae G1 cell cycle mutant gene dbf4 encodes a protein kinase and is identified as CDC5. Mol Cell Biol (1993) 3.33
SWI6 protein is required for transcription of the periodically expressed DNA synthesis genes in budding yeast. Nature (1992) 3.32
Residual symptoms after partial remission: an important outcome in depression. Psychol Med (1995) 3.23
The alpha1 and alpha2 isoforms of the AMP-activated protein kinase have similar activities in rat liver but exhibit differences in substrate specificity in vitro. FEBS Lett (1996) 3.21
Yeast SNF1 is functionally related to mammalian AMP-activated protein kinase and regulates acetyl-CoA carboxylase in vivo. J Biol Chem (1994) 3.18
Remission of epilepsy: results from the National General Practice Study of Epilepsy. Lancet (1995) 3.17
Some observations on the diagnosis of rectal gonorrhoea in both sexes using a selective culture medium. Br J Vener Dis (1966) 3.12
emm typing and validation of provisional M types for group A streptococci. Emerg Infect Dis (1999) 3.12
Dendritic cells freshly isolated from human blood express CD4 and mature into typical immunostimulatory dendritic cells after culture in monocyte-conditioned medium. J Exp Med (1993) 3.09
Immunostimulant therapy with levamisole for rheumatoid arthritis. Lancet (1976) 3.07
Structure of a mouse submaxillary messenger RNA encoding epidermal growth factor and seven related proteins. Science (1983) 2.97
Replication of HIV-1 in dendritic cell-derived syncytia at the mucosal surface of the adenoid. Science (1996) 2.95
Phenobarbital-responsive nuclear translocation of the receptor CAR in induction of the CYP2B gene. Mol Cell Biol (1999) 2.93
Cognitive therapy for major depressive disorder in primary care. Br J Psychiatry (1984) 2.86
Four new anti-inflammatory drugs: responses and variations. Br Med J (1976) 2.84
Treatment of rheumatoid arthritis with fenoprofen: comparison with aspirin. Br Med J (1974) 2.84
Recovery from chronic fatigue syndrome after treatments given in the PACE trial. Psychol Med (2013) 2.82
Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics. J Med Genet (2008) 2.81
Drowning in people with epilepsy: how great is the risk? Neurology (2008) 2.80
Practice parameters for the treatment of sigmoid diverticulitis--supporting documentation. The Standards Task Force. The American Society of Colon and Rectal Surgeons. Dis Colon Rectum (2000) 2.77
P40SDB25, a putative CDK inhibitor, has a role in the M/G1 transition in Saccharomyces cerevisiae. Genes Dev (1994) 2.72
National General Practice Study of Epilepsy: recurrence after a first seizure. Lancet (1990) 2.65
Randomised controlled trial to assess acceptability of phenobarbital for childhood epilepsy in rural India. Lancet (1998) 2.58
Risk factors for homelessness. Epidemiol Rev (1993) 2.55
DNA polymerase II, the probable homolog of mammalian DNA polymerase epsilon, replicates chromosomal DNA in the yeast Saccharomyces cerevisiae. EMBO J (1992) 2.51
Mouse prepro-epidermal growth factor synthesis by the kidney and other tissues. Nature (1985) 2.49
Vertical or horizontal visual analogue scales. Ann Rheum Dis (1979) 2.49
Hypocritical tosh. Br Dent J (2010) 2.48
Falls in the elderly related to postural imbalance. Br Med J (1977) 2.47
Lifetime and five-year prevalence of homelessness in the United States: new evidence on an old debate. Am J Orthopsychiatry (1995) 2.42
Isolation and nucleotide sequence of a cDNA encoding the precursor of mouse nerve growth factor. Nature (1983) 2.41
Adolescent suicide attempters. Response to suicide-prevention programs. JAMA (1990) 2.40
The yeast DNA polymerase I transcript is regulated in both the mitotic cell cycle and in meiosis and is also induced after DNA damage. Nucleic Acids Res (1987) 2.38
Infection of the uterine cervix with Chlamydia trachomatis. J Infect Dis (1978) 2.36
Cloning DPB3, the gene encoding the third subunit of DNA polymerase II of Saccharomyces cerevisiae. Nucleic Acids Res (1991) 2.34
Efficacy and safety of long-chain polyunsaturated fatty acid supplementation of infant-formula milk: a randomised trial. Lancet (1999) 2.34
Insulin-like growth factor-II gene expression in Wilms' tumour and embryonic tissues. Nature (1985) 2.29
Alternative to current MPH degree program. Health Serv Rep (1972) 2.28
A gene for hereditary haemorrhagic telangiectasia maps to chromosome 9q3. Nat Genet (1994) 2.26
Autobiographical memory in depression: state or trait marker? Br J Psychiatry (1993) 2.24
Slow virus visna: reproduction in vitro of virus from extrachromosomal DNA. Proc Natl Acad Sci U S A (1984) 2.24
Identification of angiotensin II receptor subtypes. Biochem Biophys Res Commun (1989) 2.23
National General Practice Study of Epilepsy: newly diagnosed epileptic seizures in a general population. Lancet (1990) 2.22
Local recurrence after laparoscopic radiofrequency thermal ablation of hepatic tumors. Ann Surg Oncol (2000) 2.21
Rapid infection of oral mucosal-associated lymphoid tissue with simian immunodeficiency virus. Science (1999) 2.21
Randomized controlled trial of brief cognitive behaviour therapy versus treatment as usual in recurrent deliberate self-harm: the POPMACT study. Psychol Med (2003) 2.16
Predictors of relapse in unipolar depressives: expressed emotion, marital distress, and perceived criticism. J Abnorm Psychol (1989) 2.16
Alteration of intestinal tight junction structure and permeability by cytoskeletal contraction. Am J Physiol (1987) 2.14
Sequence of a cDNA clone encoding human preproinsulin-like growth factor II. Nature (1984) 2.13
Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group. Lancet (1997) 2.12
Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines. J Psychopharmacol (2008) 2.11
Sleep in patients with remitted bipolar disorders: a meta-analysis of actigraphy studies. Acta Psychiatr Scand (2014) 2.10
Prophylactic treatment of postperfusion bleeding using EACA. Chest (1989) 2.09
Efficient interaction of HIV-1 with purified dendritic cells via multiple chemokine coreceptors. J Exp Med (1996) 2.08
Malaria susceptibility and CD36 mutation. Nature (2000) 2.07
An in vitro system for the editing of apolipoprotein B mRNA. Cell (1989) 2.07
Is cardiac resuscitation worthwhile? A decade of experience. N Engl J Med (1972) 2.07
Iron fortified follow on formula from 9 to 18 months improves iron status but not development or growth: a randomised trial. Arch Dis Child (1999) 2.06
Validation of a short questionnaire for estimating dietary calcium intakes. Osteoporos Int (2014) 2.06
Infection and apoptotic cell death of CD4+ T cells during an immune response to HIV-1-pulsed dendritic cells. AIDS Res Hum Retroviruses (1994) 2.05
Remission and recurrence of depression in the maintenance era: long-term outcome in a Cambridge cohort. Psychol Med (2003) 2.05
Mammalian AMP-activated protein kinase is homologous to yeast and plant protein kinases involved in the regulation of carbon metabolism. J Biol Chem (1994) 2.04
Aetiology of urinary symptoms in sexually active women. Genitourin Med (1986) 2.03
Integrated hospital and community psychiatric services and use of inpatient beds. BMJ (1989) 2.03
IGF-II induces rapid beta-catenin relocation to the nucleus during epithelium to mesenchyme transition. Oncogene (2001) 2.03
Psychological treatments for depression. An update. Br J Psychiatry (1995) 2.02
Strand displacement amplification and homogeneous real-time detection incorporated in a second-generation DNA probe system, BDProbeTecET. Clin Chem (1999) 2.01
Effect of tobacco and alcohol consumption on the Langerhans cell population of human lingual epithelium determined using a monoclonal antibody against HLADR. J Oral Pathol Med (1991) 2.00
Characterization of AMP-activated protein kinase beta and gamma subunits. Assembly of the heterotrimeric complex in vitro. J Biol Chem (1996) 1.98